Rapid Aminoglycoside NP Test for Rapid Detection of Multiple Aminoglycoside Resistance in Enterobacteriaceae.

Détails

ID Serval
serval:BIB_A749B04819EF
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Rapid Aminoglycoside NP Test for Rapid Detection of Multiple Aminoglycoside Resistance in Enterobacteriaceae.
Périodique
Journal of clinical microbiology
Auteur⸱e⸱s
Nordmann P., Jayol A., Dobias J., Poirel L.
ISSN
1098-660X (Electronic)
ISSN-L
0095-1137
Statut éditorial
Publié
Date de publication
04/2017
Peer-reviewed
Oui
Volume
55
Numéro
4
Pages
1074-1079
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
The rapid aminoglycoside NP (Nordmann/Poirel) test was developed to rapidly identify multiple aminoglycoside (AG) resistance in Enterobacteriaceae It is based on the detection of the glucose metabolism related to enterobacterial growth in the presence of a defined concentration of amikacin plus gentamicin. Formation of acid metabolites was evidenced by a color change (orange to yellow) of the red phenol pH indicator. The rapid aminoglycoside NP test was evaluated by using bacterial colonies of 18 AG-resistant isolates producing 16S rRNA methylases, 20 AG-resistant isolates expressing AG-modifying enzymes (acetyl-, adenyl-, and phosphotransferases), and 10 isolates susceptible to AG. Its sensitivity and specificity were 100% and 97%, respectively, compared to the broth dilution method, which was taken as the gold standard for determining aminoglycoside resistance. The test is inexpensive, rapid (<2 h), and implementable worldwide.

Mots-clé
Aminoglycosides/pharmacology, Anti-Bacterial Agents/pharmacology, Costs and Cost Analysis, Drug Resistance, Bacterial, Enterobacteriaceae/drug effects, Microbial Sensitivity Tests/economics, Microbial Sensitivity Tests/methods, Sensitivity and Specificity, Time Factors, 16S rRNA methylases, amikacin, antibiotic, gentamicin, kanamycin, netilmicin, plazomicin, rapid diagnostic test, susceptibility testing, tobramycin
Pubmed
Web of science
Open Access
Oui
Création de la notice
30/01/2017 20:40
Dernière modification de la notice
20/08/2019 16:12
Données d'usage